164 related articles for article (PubMed ID: 28651185)
1. Treatment of neurocognitive symptoms in unipolar depression: A systematic review and future perspectives.
Salagre E; Solé B; Tomioka Y; Fernandes BS; Hidalgo-Mazzei D; Garriga M; Jimenez E; Sanchez-Moreno J; Vieta E; Grande I
J Affect Disord; 2017 Oct; 221():205-221. PubMed ID: 28651185
[TBL] [Abstract][Full Text] [Related]
2. The prevalence, measurement, and treatment of the cognitive dimension/domain in major depressive disorder.
McIntyre RS; Xiao HX; Syeda K; Vinberg M; Carvalho AF; Mansur RB; Maruschak N; Cha DS
CNS Drugs; 2015 Jul; 29(7):577-89. PubMed ID: 26290264
[TBL] [Abstract][Full Text] [Related]
3. Systematic review of randomized controlled trials of candidate treatments for cognitive impairment in depression and methodological challenges in the field.
Miskowiak KW; Ott CV; Petersen JZ; Kessing LV
Eur Neuropsychopharmacol; 2016 Dec; 26(12):1845-1867. PubMed ID: 27745932
[TBL] [Abstract][Full Text] [Related]
4. The effectiveness of nonpharmacological interventions in older adults with depressive disorders: a systematic review.
Apóstolo J; Queirós P; Rodrigues M; Castro I; Cardoso D
JBI Database System Rev Implement Rep; 2015 Jul; 13(6):220-78. PubMed ID: 26455753
[TBL] [Abstract][Full Text] [Related]
5. Procognitive Effects of Antidepressants and Other Therapeutic Agents in Major Depressive Disorder: A Systematic Review.
Blumberg MJ; Vaccarino SR; McInerney SJ
J Clin Psychiatry; 2020 Jul; 81(4):. PubMed ID: 32726521
[TBL] [Abstract][Full Text] [Related]
6. Pharmacological Treatment of Cognitive Symptoms in Major Depressive Disorder.
Pan Z; Grovu RC; Cha DS; Carmona NE; Subramaniapillai M; Shekotikhina M; Rong C; Lee Y; McIntyre RS
CNS Neurol Disord Drug Targets; 2017; 16(8):891-899. PubMed ID: 28933261
[TBL] [Abstract][Full Text] [Related]
7. Cognition as a target in major depression: new developments.
Solé B; Jiménez E; Martinez-Aran A; Vieta E
Eur Neuropsychopharmacol; 2015 Feb; 25(2):231-47. PubMed ID: 25640673
[TBL] [Abstract][Full Text] [Related]
8. A Systematic Review and Meta-Analysis of Cognitive Training in Adults with Major Depressive Disorder.
Woolf C; Lampit A; Shahnawaz Z; Sabates J; Norrie LM; Burke D; Naismith SL; Mowszowski L
Neuropsychol Rev; 2022 Jun; 32(2):419-437. PubMed ID: 33913064
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of the benefits of exercise on cognition in major depressive disorder.
Greer TL; Furman JL; Trivedi MH
Gen Hosp Psychiatry; 2017 Nov; 49():19-25. PubMed ID: 28690019
[TBL] [Abstract][Full Text] [Related]
10. The effects of vortioxetine on cognitive dysfunction in patients with inadequate response to current antidepressants in major depressive disorder: A short-term, randomized, double-blind, exploratory study versus escitalopram.
Vieta E; Sluth LB; Olsen CK
J Affect Disord; 2018 Feb; 227():803-809. PubMed ID: 29673132
[TBL] [Abstract][Full Text] [Related]
11. Cognitive symptoms in patients with major depressive disorder and their implications for clinical practice.
Papakostas GI
J Clin Psychiatry; 2014 Jan; 75(1):8-14. PubMed ID: 24345473
[TBL] [Abstract][Full Text] [Related]
12. Characterizing neurocognitive impairment in young people with major depression: state, trait, or scar?
Allott K; Fisher CA; Amminger GP; Goodall J; Hetrick S
Brain Behav; 2016 Oct; 6(10):e00527. PubMed ID: 27781141
[TBL] [Abstract][Full Text] [Related]
13. Characterizing, Assessing, and Treating Cognitive Dysfunction in Major Depressive Disorder.
McIntyre RS; Lee Y; Carmona NE; Subramaniapillai M; Cha DS; Lee J; Lee JH; Alageel A; Rodrigues NB; Park C; Ragguett RM; Rosenblat JE; Almatham F; Pan Z; Rong C; Mansur RB
Harv Rev Psychiatry; 2018; 26(5):241-249. PubMed ID: 30188336
[TBL] [Abstract][Full Text] [Related]
14. Cognitive dysfunction in major depression: From assessment to novel therapies.
Atique-Ur-Rehman H; Neill JC
Pharmacol Ther; 2019 Oct; 202():53-71. PubMed ID: 31173838
[TBL] [Abstract][Full Text] [Related]
15. The relationship between neurocognitive and psychosocial functioning in major depressive disorder: a systematic review.
Evans VC; Iverson GL; Yatham LN; Lam RW
J Clin Psychiatry; 2014 Dec; 75(12):1359-70. PubMed ID: 25551235
[TBL] [Abstract][Full Text] [Related]
16. Major depressive disorder in breast cancer: a critical systematic review of pharmacological and psychotherapeutic clinical trials.
Carvalho AF; Hyphantis T; Sales PM; Soeiro-de-Souza MG; Macêdo DS; Cha DS; McIntyre RS; Pavlidis N
Cancer Treat Rev; 2014 Apr; 40(3):349-55. PubMed ID: 24084477
[TBL] [Abstract][Full Text] [Related]
17. Systematic reviews of randomised clinical trials examining the effects of psychotherapeutic interventions versus "no intervention" for acute major depressive disorder and a randomised trial examining the effects of "third wave" cognitive therapy versus mentalization-based treatment for acute major depressive disorder.
Jakobsen JC
Dan Med J; 2014 Oct; 61(10):B4942. PubMed ID: 25283628
[TBL] [Abstract][Full Text] [Related]
18. Cognitive remission: a novel objective for the treatment of major depression?
Bortolato B; Miskowiak KW; Köhler CA; Maes M; Fernandes BS; Berk M; Carvalho AF
BMC Med; 2016 Jan; 14():9. PubMed ID: 26801406
[TBL] [Abstract][Full Text] [Related]
19. Longitudinal course of cognitive function across treatment in patients with MDD: A meta-analysis.
Bernhardt M; Klauke S; Schröder A
J Affect Disord; 2019 Apr; 249():52-62. PubMed ID: 30753954
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
